Pluripotent Cell–specific Inhibitors (PluriSIns) to Reduce the Tumorigenic Risk of Stem Cell–based Therapies

Science-Business eXchange
doi 10.1038/scibx.2013.126
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Springer Science and Business Media LLC

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy